Head-to-head · free

Medtronic Plc vs MannKind

MDT vs MNKD — return on capital, cash generation, margins and balance sheet side by side.

MDT

6 / 8

measures where MDT leads

MNKD

2 / 8

measures where MNKD leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureMDT · FY2026MNKD · FY2025
Revenue$36.4B$349.0M
Net income$4.8B$5.9M
Revenue growth (yearly, multi-year)3.5%46.7%
Free cash flow$5.4B$13.7M
Free cash flow margin14.9%3.9%
Net cash / (debt)——
ROIC6.5%—
Return on equity9.8%—
Gross margin65.0%74.8%
Operating margin18.8%13.3%
Net debt / EBITDA2.75x5.48x

Figures are as reported by each company; latest fiscal year shown.

Where Medtronic Plc's cash went (FY2026)

Capital spending
$1.9B
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full MDT profile →

Where MannKind's cash went (FY2025)

Capital spending
$4.6M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full MNKD profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons